ASTER.CEPHAC was founded in 1975. The Aster.Cephac Group is devoted to quality, value added early drug development: Phase I - II, Proof of Concept, PK/PD and Bioanalysis studies. The group is headquartered in Paris - France and offers its services on an international scale to clients in mainland Europe, Scandinavia, the UK, the US and Japan.
R&D
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Aster.cephac
3-5 rue Eugéne
Millon
Paris
75015 France